Bank of Montreal
ZSAN

Bank of Montreal’s Zosano Pharma Corporation ZSAN Stock Holding History

Bank of Montreal’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-786
Closed -$139K – 4934
2018
Q1 		$139K Buy
+786
New +$263K ﹤0.01% 2816

Other funds holding ZSAN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Bank of Montreal's ZSAN Position: Q2 2018 in Review

Bank of Montreal sold out of Zosano Pharma Corporation (ZSAN) in Q2 2018, closing a stake of 786 shares — an estimated $139K sold.

Bank of Montreal first reported a position in ZSAN in Q1 2018 and held it in 1 quarter. The position peaked at $139K in Q1 2018. 25 funds tracked by Wall St. Rank hold ZSAN as of Q2 2018.

  • Bank of Montreal reported no remaining Zosano Pharma Corporation position as of Q2 2018 after selling out during the quarter.
  • Bank of Montreal sold 786 Zosano Pharma Corporation shares in Q2 2018, an estimated $139K.
  • Bank of Montreal first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 1 quarter.
  • Bank of Montreal's Zosano Pharma Corporation position peaked at $139K in Q1 2018.
  • 25 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2018.

Based on Bank of Montreal's 13F filing for Q2 2018, filed 16 Jul 2018.